SOMERSET THERAPEUTICS LLC recalls
3 notices naming SOMERSET THERAPEUTICS LLC as the recalling firm, since January 8, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
SOMERSET THERAPEUTICS LLC: Dexamethasone Sodium Phosphate Injection
Hazard (FDA): Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP…
FDAMedicines
SOMERSET THERAPEUTICS LLC: Cisatracurium Besylate Injection USP and 2 more
Hazard (FDA): Subpotent product:out of specification assay results observed during long term stability testing.
FDAMedicines
SOMERSET THERAPEUTICS LLC: Atropine Sulfate Ophthalmic Solution
Hazard (FDA): Failed Impurities/Degradation Specifications
FDAMedicines